Congenital Hyperinsulinism International
Congenital Hyperinsulinism International's latest filing in the PeerBasis snapshot reports a Part VII D + F figure of $114,071 for Julie Raskin, Ceo (FY 2024). Column F can include amounts from the filing and related organizations.
After indexing supported filing years to 2025 comparison dollars, the subject figure is $117,073. It is higher than the D + F figure for 10 of 27 peer organizations selected under the disclosed tier Same NTEE sector (G12), nationwide + size band 0.71–1.4× revenue (approximately 37%; median $125,010). This is descriptive, not a reasonableness conclusion.
Preparing executive-pay materials for this board?
Review the selected comparables for Congenital Hyperinsulinism International, then prepare a source-linked report and bracketed documentation worksheet for the board to verify and complete.
Review the peer setSelected peer organizations
Actual selection tier: Same NTEE sector (G12), nationwide + size band 0.71–1.4× revenue. Displayed D + F figures from supported filing years are indexed to 2025 comparison dollars with BLS CPI-U; a nationwide tier also uses 2024 BEA RPP as a consumer price-level proxy when both the subject and peer have supported state codes. Unsupported state codes receive no interstate adjustment. Comparison values can differ from the raw filing. Column F may include related-organization amounts.
| Organization | State | Revenue | D + F (2025 dollars) |
|---|---|---|---|
| Lung Cancer Initiative | NC | $1,263,567 | $124,802 |
| A Breath Of Hope Lung Foundation | MN | $1,229,594 | $175,032 |
| The Sharpe - Strumia Research Foundation | PA | $1,213,481 | $25,353 |
| Emilio Nares Foundation | CA | $1,370,788 | $129,113 |
| Diabetes Research Connection | CA | $1,176,901 | $159,780 |
| Team Phenomenal Hope | NY | $1,378,212 | $124,309 |
| Bina Stroke And Brain Injury | NY | $1,167,097 | $176,187 |
| Hnc Living Foundation | KS | $1,162,460 | $190,154 |
View the organization record and available filings on ProPublica